Today: 10 June 2026
LightPath Technologies Stock Just Hit a 52-Week High. Here’s Why LPTH Is Back in Focus
25 April 2026
2 mins read

LightPath Technologies Stock Just Hit a 52-Week High. Here’s Why LPTH Is Back in Focus

ORLANDO, Florida, April 24, 2026, 18:03 ET

  • Shares of LightPath Technologies jumped 10.05% to finish at $16.09, after touching $16.53 earlier Friday.
  • LPTH now trades above a handful of analyst targets set in recent months, upping the pressure on management to deliver.
  • Defense optics orders and infrared camera systems have been in focus for investors, with the company reporting a backlog that hit $97.8 million last quarter.

LightPath Technologies Inc. surged Friday, ending the session up 10.05% at $16.09 after hitting $16.53—marking a fresh 52-week high. Volume spiked to nearly 6.35 million shares, a sharp rise from Thursday’s 1.52 million, according to market data.

The rally’s significance? Investors are rethinking the small Orlando optics company’s pivot—from selling components to pushing upmarket with infrared camera systems, especially targeting defense and security. IR, or infrared, picks up heat signatures instead of visible light.

The stock zipped past several analyst targets. According to Benzinga, three analysts had pegged a consensus price of $13.33, with H.C. Wainwright offering the highest estimate at $15. By the end of Friday, LPTH shares were trading above both figures.

Scott Buck at H.C. Wainwright bumped up his price target on the stock to $15 from $10 back in February, maintaining a Buy call. He cited “elevated levels of demand,” mostly from the defense and security sectors. Buck highlighted an order for $9.6 million in cooled infrared cameras, along with LightPath’s $97.8 million backlog—both lending visibility to revenue for the remainder of fiscal 2026 and into fiscal 2027. StreetInsider.com

LightPath posted revenue of $16.4 million for its fiscal 2026 second quarter, jumping 120% from the same period last year. Gross profit landed at $6.0 million, a 212% surge. Adjusted EBITDA turned positive, hitting $0.6 million after recording a loss a year ago.

The messaging from the company has been clear. In February, Chief Executive Sam Rubin pointed to “accelerating revenue growth on strong orders,” crediting sales from G5 Infrared’s cameras and modules. PR Newswire

LightPath wants to shake its image as just a component supplier. The annual report outlines plans to pivot toward imaging subsystems and full systems, with BlackDiamond chalcogenide glass at the center. The material—used in infrared optics and positioned as a germanium alternative—is the company’s bet for this shift.

The company’s play here has a defense component. LightPath points to its cooled camera tech for long-range, border security, and anti-drone operations. They also argue the BlackDiamond materials help sidestep germanium bottlenecks.

Management’s been fleshing out its sales team lately. LightPath tapped Doug Schoen for senior VP of global sales and brought on Ryan Workman as VP of business development and product management on April 8. CEO Rubin said these additions are meant to help turn a “strong backlog into sustained revenue growth.” PR Newswire

LightPath isn’t alone in the space. Its annual report lays out competition on multiple fronts: raw materials, lenses, assemblies, and cameras. The company lists Teledyne FLIR as one of its rivals for standard products. Defense giants like Lockheed Martin and RTX show up on both sides of the ledger—they can be customers, but they’re also competitors.

The stock’s recent jump doesn’t leave much margin for setbacks. LightPath posted a second-quarter net loss of $9.4 million, deeper than the $2.6 million loss a year ago—acquisition-linked fair-value adjustments played a role. The company’s filings flag risks: rivals, pricing squeezes, customer sign-off delays, or softer demand could all weigh on results.

Right now, investors are chasing the defense-optics narrative, shelling out even before the company can prove steady profits. The real question: will that backlog actually convert to revenue as quickly as the market’s betting it will?

Stock Market Today

  • $4 Treatment for Flesh-Eating Screwworm Threatens U.S. Livestock
    June 10, 2026, 10:47 AM EDT. A flesh-eating parasitic fly, the screwworm, has re-emerged as a threat to U.S. livestock after being eradicated 60 years ago. Ranchers and veterinarians endorse a $4 treatment to combat the infestation. The treatment offers a cost-effective solution to protect cattle, helping contain the spread and lessen economic losses. This development has significant implications for the livestock industry as farmers seek to safeguard their herds from this destructive parasite.

Latest articles

Nu Holdings Stock Moves Higher, Investors Weigh $1 Billion Buyback Impact

Nu Holdings Stock Moves Higher, Investors Weigh $1 Billion Buyback Impact

10 June 2026
Nu Holdings stock rebounded 1.3% to $12.04 early Wednesday after a $1 billion buyback was authorized, but shares remain down 30.5% over six months as investors weigh the buyback’s support against rising credit costs, a CFO transition that triggered analyst downgrades, and a jump in non-performing loans to 5.0% last quarter.
Keel Infrastructure Inches Up After $458M Debt Deal Amid AI Pivot

Keel Infrastructure Inches Up After $458M Debt Deal Amid AI Pivot

10 June 2026
Keel Infrastructure jumped 0.83% to $5.47 after closing a $458 million convertible-note sale, up from an initial $350 million plan, with proceeds aimed at AI data-center growth and capped calls to limit dilution up to $11.86 per share, as investors weigh new capital against added debt and future share issuance.
Wolfspeed Stock Jumps 13% Before May 5 Earnings Test
Previous Story

Wolfspeed Stock Jumps 13% Before May 5 Earnings Test

X-Energy Stock Jumps in Nasdaq Debut as $1 Billion Nuclear IPO Tests AI Power Boom
Next Story

X-Energy Stock Jumps in Nasdaq Debut as $1 Billion Nuclear IPO Tests AI Power Boom

Go toTop